Drug Channels

OCTOBER 5, 2021

I am pleased to announce our new 2021–22 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors , available for purchase and immediate download. analyzes how marketplace dynamics of provider-administered biosimilars affect wholesalers’ gross margins. The exhibits appear in all license versions. Section 4.4.

Pharmaceuticals 75

Pharmaceuticals Biosimilars Licensing Licensing 75

Drug Channels

OCTOBER 11, 2022

I am pleased to announce our new 2022–23 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors , available for purchase and immediate download. Click here to download a free report overview (including a summary of industry trends, the Table of Contents, and a List of Exhibits) New Drug Channels Institute Study: U.S.

Pharmaceuticals 74

Pharmaceuticals Biosimilars Licensing Licensing 74

Drug Channels

FEBRUARY 21, 2023

Those who preorder will receive a download link before March 14. CLICK HERE to download a free pre-publication overview (including key industry trends, the Table of Contents, and a List of Exhibits). Download a free report overview for more details on the new sections and content. Copyright © 2006-2023 Pembroke Consulting, Inc.

Pharmacy 97

Pharmacy Specialty Pharmacies Licensing Licensing 97

Drug Channels

SEPTEMBER 17, 2024

Those who preorder will receive a download link before October 8. We are providing you with the opportunity to preorder this thoroughly updated, revised, and expanded 2024-25 edition at special discounted prices. This means that you can be among the first to access our new report.

Pharmaceuticals 52

Pharmaceuticals Licensing Licensing Drugs 52

Drug Channels

SEPTEMBER 12, 2023

Those who preorder will receive a download link before October 10. CLICK HERE to download a free pre-publication overview (including key industry trends, the Table of Contents, and a List of Exhibits) You can pay online with all major credit cards (Visa, MasterCard, American Express, and Discover) or via PayPal.

Pharmaceuticals 40

Pharmaceuticals Pharmacy Biosimilars Licensing 40

The Pharma Data

SEPTEMBER 16, 2020

We develop product candidates internally and through licensing collaborations, partnerships and joint ventures. View original content to download multimedia: [link]. Even when clinical trials are successful, regulatory authorities may question the sufficiency for approval of the trial endpoints we have selected. SOURCE Amgen.

Clinical Trials 52

Clinical Trials Production Trials Government 52

The Pharma Data

SEPTEMBER 20, 2020

We develop product candidates internally and through licensing collaborations, partnerships and joint ventures. View original content to download multimedia: [link]. Even when clinical trials are successful, regulatory authorities may question the sufficiency for approval of the trial endpoints we have selected. 2019;38:2953-2966.

Clinical Trials 52

Clinical Trials Production Trials Government 52